Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Therapeutic outcomes and prognostic determinants of neoadjuvant chemotherapy plus interval debulking surgery compared with primary debulking surgery in advanced-stage epithelial ovarian cancer

Objective To compare the therapeutic outcomes of neoadjuvant chemotherapy followed by interval debulking surgery (NACT-IDS) and primary debulking surgery (PDS) in patients with advanced epithelial ovarian cancer (AEOC) and to evaluate factors associated with prognosis. Methods This retrospective study included 97 patie...

Yan Ma, Meng-Li Xu, Qi Zhang et al. · 0 citations
Open access Oct 2026

Expression of V‑domain Ig suppressor of T cell activation in ovarian cancer and its regulation of follicular regulatory T‑cell function via the AKT/MAPK pathway.

The high mortality associated with ovarian cancer is closely linked to immune remodeling within the tumor microenvironment (TME). V‑domain Ig suppressor of T cell activation (VISTA), a novel immune checkpoint, has attracted increasing attention in tumor immunology; however, its effects on follicular regulatory T (Tfr)...

Yan Ma, Yi-Dan Xu, Chun-Xia Yu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.